[THC Exports to U.S.] Catch Up on CBT's Top 10 Articles: February

If you cannot view this email, please click here.

International Cannabis Commerce With U.S.?

When Pure Jamaican announced Feb. 22 that it was shipping its first legal exports of THC to the U.S. for analytical testing, Cannabis Business Times’ readers quickly took notice with surging web traffic.

This news, delivered as a press release to our CBT audience, marks the first time that republished content topped our monthly list of top 10 articles since launching this feature in September.

What made this news so popular? Perhaps the thought of international cannabis trade coming to the U.S. despite ongoing federal prohibition that outlaws even interstate commerce among state-legal programs sparked readers’ interest.

Pure Jamaica and its GMP-certified licensed pharma manufacturer, Seven-10 Pharmaceuticals, intend to request U.S. Drug Enforcement Administration (DEA) permits to ship THC products from Jamaica to the U.S. once the DEA reschedules cannabis. First, as noted in the press release, the company shipped its products to a DEA-licensed facility in the U.S. for analytical testing.

On that rescheduling note, five of this month’s most-read articles dealt with the DEA’s pending decision to potentially reclassify cannabis as a Schedule III drug under the Controlled Substances Act (CSA). In the No. 2 spot was an article about the DEA and Attorney General missing a deadline to respond to a letter from 12 U.S. senators, which CBT confirmed with multiple congressional staffers. Also on the list was a feature on the history behind NORML’s first rescheduling petition, one that lasted 22 years, which shed light on the DEA’s 1975 admission that rescheduling cannabis does not violate an international drug treaty.

Among other articles readers engaged with most this month were CBT’s January/February cover story, “Lume’s Rapid Rise”—on how Michigan’s largest operator scaled from $2 million to nearly $200 million in revenue in just four years—as well as the prospects for medical cannabis legalization in nine of our nation’s last holdouts.

UPDATE: South Carolina Senate Approves Medical Cannabis Legalization Bill

The state’s Compassionate Care Act is lined up to face scrutiny in the House, where it died on a procedural vote in 2022. More >>>

Cannabis Reform Momentum Unprecedented in Recent Years

In the past three years, the federal government has taken steps to provide more access to research, rescheduling may be on the horizon and nearly half of U.S. states have legalized adult-use cannabis. More >>>

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty. More >>>

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule. More >>>

VP Kamala Harris Touts Changing ‘Federal Marijuana Policy’ in Campaign Video

Many industry stakeholders and advocates pushed back, saying the White House hasn’t changed anything since Biden took office. More >>>

Lume’s Rapid Rise

How Lume Cannabis Co. has flourished—growing from $2 million to nearly $200 million in revenue in four years—amid Michigan’s plunging retail prices and other challenges. More >>>

Will These 9 Prohibition States Legalize Medical Cannabis in 2024?

From politics to ballot initiative processes, CBT takes a hard look at the possibilities for reform among our nation’s last holdouts. More >>>

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process. More >>>

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency. More >>>

Jamaica Company Ships 1st Legal Exports of THC to United States For DEA Testing

Pure Jamaican elevates Jamaica as a global provider of legal cannabis with pharmaceutical THC product exports to the U.S. and Brazil. More >>>

About CBT:
Cannabis Business Times is the most trusted source of actionable intelligence for plant-touching cannabis businesses throughout North America and is producer of the industry-leading Cannabis Business Times Conference.